These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3061413)

  • 21. HIV DNA and antibodies in syringes from injecting drug users: a comparison of detection techniques.
    Myers SS; Heimer R; Liu D; Henrard D
    AIDS; 1993 Jul; 7(7):925-31. PubMed ID: 8357554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV antibody EIA and western blot assay results on paired serum and saliva specimens.
    Fitzgibbons D; Barriga G; Seymour E; Stramer S
    Ann N Y Acad Sci; 1993 Sep; 694():314-6. PubMed ID: 8215076
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV antibody testing by a displacement pool method lacks sensitivity and is unsuitable for blood donor screening.
    Heyns AD; Kuun E; Brashaw M
    Vox Sang; 1996; 71(1):61-3. PubMed ID: 8837361
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of anti-HIV-1 antibodies in bloodstains of various ages.
    Pappalardo G; Sermasi G; Re MC; Furlini G; Pelotti S; Malferrari F
    Int J Legal Med; 1991 Mar; 104(2):63-5. PubMed ID: 2054305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of eight commercial test kits for detecting anti-HIV antibodies in saliva specimens.
    Chamnanput J; Phanuphak P
    AIDS; 1993 Jul; 7(7):1026. PubMed ID: 8357553
    [No Abstract]   [Full Text] [Related]  

  • 26. [Follow-up study of anti-HIV reactive blood donors].
    Caspari G; Beyer J; Schunter F; Knüver-Hopf J; Schmitt H
    Beitr Infusionsther; 1988; 21():153-6. PubMed ID: 2462966
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel.
    Thorstensson R; Andersson S; Lindbäck S; Dias F; Mhalu F; Gaines H; Biberfeld G
    J Virol Methods; 1998 Feb; 70(2):139-51. PubMed ID: 9562408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioimmune western blotting in comparison with conventional western blotting, second and third generation ELISA assays for the serodiagnosis of HIV-1 infection.
    Portincasa P; Conti G; Zannino T; Visalli S; Chezzi C
    New Microbiol; 1994 Jul; 17(3):169-76. PubMed ID: 7968651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discrimination of HIV-1 and HIV-2 infection based on recombinant immunoblots.
    Baur A; Erlwein O; Ehrmann U; Jahn G
    J Virol Methods; 1989 Jun; 24(3):275-83. PubMed ID: 2668318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New tests produced by Organon Teknika for the diagnosis of antibodies to HIV-1 and HIV-2.
    Chantrain C
    Przegl Epidemiol; 1992; 46(1-2):3-10. PubMed ID: 1475387
    [No Abstract]   [Full Text] [Related]  

  • 31. Seronegativity and HIV infection.
    Lepage P; Batungwanayo J; Van de Perre P
    Arch Dis Child; 1989 Jan; 64(1):135-7. PubMed ID: 2647031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult and paediatric AIDS patients lacking HIV antibodies detected by enzyme immunoassay in central Africa: further serological studies.
    Van de Perre P; Lepage P; Batungwanayo J; Bonnet D
    AIDS; 1989 Jul; 3(7):429-31. PubMed ID: 2504245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
    Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
    J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update: serologic testing for antibody to human immunodeficiency virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Jan; 36(52):833-40, 845. PubMed ID: 3121999
    [No Abstract]   [Full Text] [Related]  

  • 35. The "window of negativity" of HIV antibody tests.
    Pazin GJ
    Pa Med; 1989 Jul; 92(7):38. PubMed ID: 2755705
    [No Abstract]   [Full Text] [Related]  

  • 36. Factors influencing HIV-1 banding patterns in miniaturized western blot testing of dried blood spot specimens.
    Granade TC; Phillips SK; Bell CJ; Pau CP; Parekh B; Hannon WH; Gwinn M; Redus MA; Schochetman G; George JR
    J Immunol Methods; 1992 Oct; 154(2):225-33. PubMed ID: 1401956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leads from the MMWR. Update: serologic testing for antibody to human immunodeficiency virus.
    JAMA; 1988 Feb; 259(5):653, 656, 662-4. PubMed ID: 3275818
    [No Abstract]   [Full Text] [Related]  

  • 38. Human immunodeficiency virus infection elicits early antibody not detected by standard tests: implications for diagnostics and viral immunology.
    Race EM; Ramsey KM; Lucia HL; Cloyd MW
    Virology; 1991 Oct; 184(2):716-22. PubMed ID: 1887591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three cases of transient HIV-1 seropositivity observed in 10 years of practice of a national HIV confirmatory laboratory.
    Tarján V; Ujhelyi E; Kellner R; Králl G; Gyuris A; Mihály I; Füst G
    AIDS; 1998 Jan; 12(1):120-1. PubMed ID: 9456268
    [No Abstract]   [Full Text] [Related]  

  • 40. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24).
    Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D
    J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.